Share This

PR Newswire Asia's news > Medical/Pharmaceuticals

 |   Title only   |   Print    Next page > 
     
OBiO Technology will showcase at American Society of Gene & Cell Therapy
-Visit  OBiO Tech booth #1644  at  American Society of Gene & Cell Therapy in Maryland, USA ...
2024-04-29T    Health Care/Hospital   Medical/Pharmaceuticals   Trade show news 
MGI Tech opens Customer Experience Center in Brazil to contribute to the advancement of genomics in Latin America
The laboratory has state-of-the-art technology to support medical research of clinical labs and healthcare institutions, improving precision diagnoses and treatments. The agricultural sector can also ...
2024-04-28T    Computer/Electronics   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Pierre Fabre Laboratories receive positive CHMP opinion for OBGEMSA™(vibegron) in overactive bladder syndrome
CASTRES, France , April 26, 2024 /PRNewswire/ -- Pierre Fabre Laboratories announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted ...
2024-04-26T    Health Care/Hospital   Medical/Pharmaceuticals 
United Imaging Healthcare releases 2023 annual report, with revenue growth of 23.52%
Along with the publication of its 2023 annual report and the Q1 2024 report, United Imaging Healthcare released its ESG report. ...
2024-04-26T    Banking/Financial Service   Health Care/Hospital   Medical/Pharmaceuticals 
United Imaging Healthcare Releases 2023 ESG Report, Advancing Mission of Equal Healthcare for All™
SHANGHAI , April 27, 2024 /PRNewswire/ -- United Imaging Healthcare (SSE:688271) has published its 2023 Environment, Social, and Governance (ESG) Report, reaffirming its mission to bring Equal Healthcare ...
2024-04-26T    Health Care/Hospital   Internet Technology   Medical Equipment   Medical/Pharmaceuticals 
New President Appointed for Nitto Denko Avecia Inc.
MILFORD, Mass. , April 26, 2024 /PRNewswire/ -- Nitto Denko Avecia Inc. and Nitto Denko Avecia Pharma Services (Nitto Avecia), a global leader in contract development and manufacturing of oligonucleotides ...
2024-04-26T    Health Care/Hospital   Medical/Pharmaceuticals 
Ractigen Therapeutics Announces FDA Approval for RAG-01, a First-in-Class saRNA Therapy for BCG-Unresponsive NMIBC
SUZHOU, China , April 26, 2024 /PRNewswire/ -- Ractigen Therapeutics, a leader in the development of small activating RNA (saRNA) therapeutics, announced today that the U.S. Food and Drug Administration ...
2024-04-26T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Novel T-cell engager, CDH17 X CD3 cabotamig (ARB202) continues to explore dosing in patients with advanced gastrointestinal cancers
The second DMC review recommends the continuation of dose escalation in the clinical trial as per protocol. The interim safety assessment was based on the review of safety data from 18 metastatic gastrointestinal ...
2024-04-26T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
OMRON Donates Some 3,200 Units of Blood Pressure Monitors to Global Blood Pressure Screening Campaign on World Hypertension Day
KYOTO, Japan , April 26, 2024 /PRNewswire/ -- OMRON Healthcare Co., Ltd. based in Muko, Kyoto Prefecture , Japan , announces to be the official sponsor of May Measurement Month (MMM,) a global ...
2024-04-26T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Fosun Pharma's Self-developed Artemisinin Medicines Inject New Impetus to Malaria Prevention and Treatment in Africa
SHANGHAI , April 26, 2024 /PRNewswire/ -- World Malaria Day is marked each year on April 25 . World Health Organization (WHO) gave as the theme for World Malaria Day 2024 Accelerating the fight ...
2024-04-26T    Biotechnology   Health Care/Hospital   Infectious Disease Control   Medical/Pharmaceuticals 
  Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.